Clinical trials
Observational Pancreatic Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 13 |
| Unknown status | 7 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 5 |
| Royal Marsden NHS Foundation Trust | 4 |
| AstraZeneca | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 2 |
| University Hospital Plymouth NHS Trust | 2 |
| University of Edinburgh | 2 |
| Arbor Research Collaborative for Health | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Bournemouth University | 1 |
| Cancer Research UK | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 38 |
| Esophageal Neoplasms | 9 |
| Colorectal Neoplasms | 8 |
| Stomach Neoplasms | 7 |
| Urinary Bladder Neoplasms | 6 |
| Cholangiocarcinoma | 5 |
| Neoplasms | 5 |
| Biliary Tract Neoplasms | 4 |
| Liver Neoplasms | 3 |
| Lung Neoplasms | 3 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.